Paul Gibson - McMaster Experts

Affiliations

Faculty of Health Sciences, McMaster University
Associate Professor, Pediatrics, Faculty of Health Sciences
Associate Medical Director, Pediatric Oncology Group of Ontario,
Pediatric Oncologist, McMaster Children's Hospital,
Associate Chief Medical Information Officer, Hamilton Health Sciences,
Pediatric Oncologist, Children's Hospital London Health Sciences,
Associate Professor, Pediatrics, Western University
Assistant Professor, Pediatrics, Western University

Scholarly Activity in McMaster Experts

Co-author Network

Scholarly Activity
Background
Contact
View All

selected scholarly activity

chapters
- B Cell Leukemia and Lymphoma. 279-286. 2016
conferences
- Cost-utility of nelarabine for the first-line treatment of newly diagnosed pediatric T-cell acute lymphoblastic leukemia in Canada.. Pediatric Blood and Cancer. e31393. 2025
- DEVELOPMENT AND EXPANSION OF A CANADIAN SURVEILLANCE POPULATION HEALTH TOOL FOR CHILDREN AND YOUTH WITH CANCER. Pediatric Blood and Cancer. S486-S486. 2023
- HIGH QUALITY CARE CLOSE TO HOME: THE POGO SATELLITE PROGRAM. Pediatric Blood and Cancer. S481-S481. 2023
- IMPROVING ACCESS TO HIGH-POTENTIAL PEDIATRIC PRECISION THERAPIES: A CHILD-TAILORED ASSESSMENT FRAMEWORK TO DETERMINE VALUE FOR FUNDING DECISIONS. Pediatric Blood and Cancer. S473-S474. 2023
- RELAPSED WILMS TUMOR MANAGEMENT AND OUTCOMES IN CANADA. Pediatric Blood and Cancer. S84-S85. 2023
- Addressing adherence to guidelines on prevention of acute chemotherapy‐induced nausea and vomiting in pediatric patients. Pediatric Blood and Cancer. e30210. 2023
- CREATING AND ADAPTING AN INFECTION MANAGEMENT CARE PATHWAY IN PEDIATRIC ONCOLOGY. Pediatric Blood and Cancer. 2022
- PREDICTORS OF PRE-MAINTENANCE DELAYS DURING THERAPY AND ASSOCIATIONS WITH OUTCOME AMONG CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA: A POPULATION-BASED STUDY. Pediatric Blood and Cancer. 2022
- Development and Validation of a Childhood Acute Lymphoblastic Leukemia Policy Model Constructed Using Real World Population-Based Data. Pediatric Blood and Cancer. S111-S111. 2021
- Healthcare Utilization and Costs Associated with Acute Lymphoblastic Leukemia (ALL) in Children with and without Down Syndrome (DS): A Population-Based Study. Pediatric Blood and Cancer. S186-S187. 2021
- The First Wave of The Covid-19 Pandemic Did Not Affect Childhood Cancer Incidence In Canada: A Report from Cyp-C. Pediatric Blood and Cancer. S136-S137. 2021
- PHASE-SPECIFIC RISKS OF EMERGENCY VISITS AND HOSPITALIZATIONS DURING COG-BASED ALL TREATMENT. Pediatric Blood and Cancer. S50-S50. 2021
- Performance of an Ehealth Decision Support Tool (MIPOGG) for Identifying Children With Constitutional Mismatch Repair Deficiency, DICER1 Syndrome, Gorlin Syndrome and Li-Fraumeni Syndrome. Pediatric Blood and Cancer. S218-S218. 2020
- The Cancer in Young People in Canada Data Tool: An Interactive Display of the Incidence, Survival, and Recurrence of Childhood Cancer in Canada, 2001-2016. Pediatric Blood and Cancer. S131-S131. 2020
- Performance of an E-Health Decision-Support Tool for Identifying Cancer Predisposition Syndromes in Canadian Pediatric Oncology Centres. Pediatric Blood and Cancer. S72-S73. 2019
- COMPARISON OF HEMATOPOIETIC STEM CELL TRANSPLANTATION CONDITIONING REGIMENS FOR PEDIATRIC HLH. Pediatric Blood and Cancer. 2019
- HIGH VS. LOW-INTENSITY BRIDGING CHEMOTHERAPY WHEN AWAITING CAR-T THERAPY: A POPULATION- BASED STUDY. Pediatric Blood and Cancer. 2019
- IMPACT OF CHILDHOOD CANCER DRUG WASTAGE ON PEDIATRIC ONCOLOGY PROGRAMS IN ONTARIO, CANADA. Pediatric Blood and Cancer. 2019
- High Vs. Low-Intensity Bridging Chemotherapy in Children with Acute Lymphoblastic Leukemia Awaiting Chimeric Antigen Receptor T-Cell Therapy: A Population-Based Study from Ontario, Canada. Blood. 1410-1410. 2018
- Increasing Incidence and Prevalence of Pathologic Hemoglobinopathies Among Children in Ontario, Canada from 1991-2013. Blood. 4698-4698. 2018
- Ongoing recurrent hospitalization, malignancy, and mortality among survivors of childhood hematopoietic stem cell transplantation performed for non-malignant indications. Bone Marrow Transplantation. 125-126. 2018
- Design and Implementation of Comprehensive Inpatient and Outpatient CPOE in a Paediatric Oncology Centre. Pediatric Blood and Cancer. S221-S221. 2016
- Olanzapine for Chemotherapy-Induced Nausea and Vomiting (CINV) Prophylaxis in Children: A Multi-Centre Feasibility Study. Pediatric Blood and Cancer. S278-S278. 2016
- LACK OF TREATMENT-RELATED MORTALITY DEFINITIONS IN STUDIES OF CHILDREN, ADOLESCENTS AND YOUNG ADULTS WITH LYMPHOMAS, SOLID TUMORS AND BRAIN TUMORS: A SYSTEMATIC REVIEW. Pediatric Blood and Cancer. S403-S403. 2014
- PREDICTORS OF CANCER DIAGNOSTIC INTERVALS AND ASSOCIATIONS WITH OUTCOME IN CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA: A POPULATION-BASED COHORT STUDY USING HEALTH SERVICES DATA. Pediatric Blood and Cancer. S81-S81. 2014
- INITIAL DEVELOPMENT OF THE SYMPTOM SCREENING IN PEDIATRIC TOOL (SSPEDI). Pediatric Blood and Cancer. 169-169. 2013
- PEDIATRIC ONCOLOGY GROUP OF ONTARIO (POGO) GUIDELINES FOR PREVENTION OF ANTINEOPLASTIC-INDUCED NAUSEA AND VOMITING (AINV) IN CHILDREN: ACUTE AND ANTICIPATORY AINV. Pediatric Blood and Cancer. 27-27. 2013
- Cyclosporine Area Under the Curve in Children Undergoing Haematopoietic Stem Cell Transplantation: Limited Sampling Strategy at Steady-State. Transplantation and Cellular Therapy. S308-S308. 2012
- DO NUCLEAR MEDICINE GFR STUDIES CONTRIBUTE TO THERAPEUTIC DECISION MAKING IN PEDIATRIC ONCOLOGY PATIENTS RECEIVING CHEMOTHERAPY?. Pediatric Blood and Cancer. 937-938. 2011
- CD56 EXPRESSION AS A PROGNOSTIC INDICATOR IN PEDIATRIC AML: A SINGLE CENTRE REVIEW. Pediatric Blood and Cancer. 828-828. 2010
- ACINIC CELL CARCINOMA: CUT IT OUT ..... THEN WHAT?. Pediatric Blood and Cancer. 738-738. 2009
journal articles
- Symptom Screening for Hospitalized Pediatric Patients With Cancer: A Randomized Clinical Trial.. JAMA Pediatrics. 179:11-18. 2025
- Development of a Value Assessment Framework for Pediatric Health Technologies Using Multicriteria Decision Analysis: Expanding the Value Lens for Funding Decision Making. Value in Health. 27:879-888. 2024
- Healthcare professional perspectives following implementation of an infection management care pathway for pediatric patients with cancer: a qualitative study. Supportive Care in Cancer. 32:405. 2024
- Tubular Injury Biomarkers to Predict CKD and Hypertension at 3 Months Post-Cisplatin in Children. Kidney360. 5:821-833. 2024
- Urinary TIMP-2*IGFBP-7 to diagnose acute kidney injury in children receiving cisplatin. Pediatric Nephrology. 39:269-282. 2024
- Performance of the eHealth decision support tool, MIPOGG, for recognising children with Li-Fraumeni, DICER1, Constitutional mismatch repair deficiency and Gorlin syndromes. Journal of Medical Genetics. 60:1218-1223. 2023
- Rates and predictors of visits to primary care physicians during and after treatment of childhood acute lymphoblastic leukemia: A population‐based cohort study. Pediatric Blood and Cancer. 70:e30610. 2023
- Outcomes of Coronavirus Disease 2019 Infection in Children and Adolescents With Cancer in Canada: Population-based Study and Systematic Review. Journal of Pediatric Hematology/Oncology. 45:e689-e694. 2023
- Treatment of breakthrough and prevention of refractory chemotherapy‐induced nausea and vomiting in pediatric cancer patients: Clinical practice guideline update. Pediatric Blood and Cancer. 70:e30395. 2023
- Case Report: Prolonged remission of metastatic cisplatin-refractory nasopharyngeal carcinoma with Pembrolizumab. Frontiers in Oncology. 13:1249453. 2023
- Prevention of acute and delayed chemotherapy‐induced nausea and vomiting in pediatric cancer patients: A clinical practice guideline. Pediatric Blood and Cancer. 69:e30001. 2022
- Temporal clustering of neuroblastic tumours in children and young adults from Ontario, Canada. Environmental Health: A Global Access Science Source. 21:30. 2022
- Interventions for the prevention of acute phase chemotherapy-induced nausea and vomiting in adult and pediatric patients: a systematic review and meta-analysis. Supportive Care in Cancer. 30:8855-8869. 2022
- Creating and adapting an infection management care pathway in pediatric oncology. Supportive Care in Cancer. 30:7923-7934. 2022
- Healthcare utilization and costs associated with acute lymphoblastic leukemia in children with and without Down syndrome. Pediatric Blood and Cancer. 69:e29829. 2022
- Creating Video-Based Education Modules for Parents of Newly Diagnosed Pediatric Patients With Cancer. Cancer Nursing. 45:E428-E435. 2022
- KIdney aNd blooD prESsure ouTcomes in Childhood Cancer Survivors: Description of Clinical Research Protocol of the KINDEST-CCS Study. Canadian Journal of Kidney Health and Disease. 9:205435812211301-205435812211301. 2022
- Performance of the McGill Interactive Pediatric OncoGenetic Guidelines for Identifying Cancer Predisposition Syndromes. JAMA Oncology. 7:1806-1806. 2021
- Incidence of childhood cancer in Canada during the COVID-19 pandemic. CANADIAN MEDICAL ASSOCIATION JOURNAL. 193:E1798-E1806. 2021
- Blinatumomab Is Cost-Effective Compared to Standard Chemotherapy for Children with High Risk Relapses of Acute Lymphoblastic Leukemia: A Cost-Effectiveness Analysis Using Population-Based Healthcare Data. Blood. 138:565-565. 2021
- Rates and Predictors of Visits to Primary Care Physicians during and after Treatment of Childhood Acute Lymphoblastic Leukemia: A Population-Based Cohort Study. Blood. 138:839-839. 2021
- Identifying clinical practice guidelines for symptom control in pediatric oncology. Supportive Care in Cancer. 29:7049-7055. 2021
- Utility of a Cancer Predisposition Screening Tool for Predicting Subsequent Malignant Neoplasms in Childhood Cancer Survivors. Journal of Clinical Oncology. 39:3207-3216. 2021
- Phase‐specific risks of outpatient visits, emergency visits, and hospitalizations during Children's Oncology Group‐based treatment for childhood acute lymphoblastic leukemia: A population‐based study. Pediatric Blood and Cancer. 68:e29141. 2021
- Clinical practice guideline for the prevention of oral and oropharyngeal mucositis in pediatric cancer and hematopoietic stem cell transplant patients: 2021 update. European Journal of Cancer. 154:92-101. 2021
- Health care utilisation and costs associated with different treatment protocols for newly diagnosed childhood acute lymphoblastic leukaemia: A population-based study in Ontario, Canada. European Journal of Cancer. 151:126-135. 2021
- Diagnostic discrepancies between antemortem clinical diagnosis and autopsy findings in pediatric cancer patients. Virchows Archiv. 478:1179-1185. 2021
- Feeling scared or worried self-report in children receiving cancer treatments using the Symptom Screening in Pediatrics Tool (SSPedi). Supportive Care in Cancer. 29:3137-3144. 2021
- Predictors of clinical trial enrollment and impact on outcome in children and adolescents with acute lymphoblastic leukemia: A population based study.. Journal of Clinical Oncology. 39:7031-7031. 2021
- Prevention and treatment of anticipatory chemotherapy‐induced nausea and vomiting in pediatric cancer patients and hematopoietic stem cell recipients: Clinical practice guideline update. Pediatric Blood and Cancer. 68:e28947. 2021
- A Population-Based Study of COVID-19 Infection Among Childhood Cancer Survivors. Frontiers in Medicine. 8:718316. 2021
- Radiological Assessment and Outcome of Local Disease Progression after Neoadjuvant Chemotherapy in Children and Adolescents with Localized Osteosarcoma. Journal of Clinical Medicine. 9:4070-4070. 2020
- Healthcare Utilization and Costs Associated with Different Treatment Protocols for Newly Diagnosed Childhood Acute Lymphoblastic Leukemia: A Population-Based Study. Blood. 136:46-47. 2020
- Effect of different conditioning regimens on survival and engraftment for children with hemophagocytic lymphohistiocytosis undergoing allogeneic hematopoeitic stem cell transplantation: A single institution experience. Pediatric Blood and Cancer. 67:e28477. 2020
- Assessing Parents’ Needs in Using Phone Applications to Improve Medication Adherence in an Outpatient Pediatric Oncology Clinic. Journal of Pediatric Hematology/Oncology. 42:e277-e280. 2020
- Recommendations for medical care in the pediatric oncology camp setting: Consensus statements based on Delphi methodology. Pediatric Blood and Cancer. 67:e28107. 2020
- Managing pregnancy-associated clinical emergencies in systemic lupus erythematosus: a case-based approach.. Expert Review of Clinical Immunology. 16:5-22. 2020
- Severely bothersome fatigue in children and adolescents with cancer and hematopoietic stem cell transplant recipients. Supportive Care in Cancer. 27:2665-2671. 2019
- Taste changes in children with cancer and hematopoietic stem cell transplant recipients. Supportive Care in Cancer. 27:2247-2254. 2019
- Classification of the acute emetogenicity of chemotherapy in pediatric patients: A clinical practice guideline. Pediatric Blood and Cancer. 66:e27646. 2019
- Validation of the Proxy Version of Symptom Screening in Pediatrics Tool in Children Receiving Cancer Treatments. Journal of Pain and Symptom Management. 56:107-112. 2018
- Validation of the Symptom Screening in Pediatrics Tool in Children Receiving Cancer Treatments. Journal of the National Cancer Institute. 110:661-668. 2018
- Relationship between cyclosporine area-under-the curve and acute graft versus host disease in pediatric patients undergoing hematopoietic stem cell transplant: A prospective, multicenter study. Pediatric Hematology and Oncology. 35:288-296. 2018
- Describing symptoms using the Symptom Screening in Pediatrics Tool in hospitalized children with cancer and hematopoietic stem cell transplant recipients. Cancer Medicine. 7:1750-1755. 2018
- Pediatric oncology clinical trial participation where the geography is vast: Development of a clinical research system for tertiary and satellite centers in Ontario, Canada. Pediatric Blood and Cancer. 65. 2018
- Evaluation of the electronic self-report Symptom Screening in Pediatrics Tool (SSPedi). BMJ Supportive and Palliative Care. 8:110-116. 2018
- Treatment‐related mortality in newly diagnosed pediatric cancer: a population‐based analysis. Cancer Medicine. 7:707-715. 2018
- Nusinersen versus Sham Control in Later-Onset Spinal Muscular Atrophy. New England Journal of Medicine. 378:625-635. 2018
- Olanzapine for prevention of chemotherapy-induced nausea and vomiting in children and adolescents: a multi-center, feasibility study. Supportive Care in Cancer. 26:549-555. 2018
- Guideline for the prevention of acute chemotherapy‐induced nausea and vomiting in pediatric cancer patients: A focused update. Pediatric Blood and Cancer. 64. 2017
- Guideline for the prevention of oral and oropharyngeal mucositis in children receiving treatment for cancer or undergoing haematopoietic stem cell transplantation. BMJ Supportive and Palliative Care. 7:7-16. 2017
- Evaluation of treatment-related mortality among paediatric cancer deaths: a population based analysis. British Journal of Cancer. 116:540-545. 2017
- Guideline for the Treatment of Breakthrough and the Prevention of Refractory Chemotherapy‐Induced Nausea and Vomiting in Children With Cancer. Pediatric Blood and Cancer. 63:1144-1151. 2016
- Minimal Residual Disease and Childhood Leukemia: Standard of Care Recommendations From the Pediatric Oncology Group of Ontario MRD Working Group. Pediatric Blood and Cancer. 63:973-982. 2016
- Methodological issues identified during cognitive interviews in the development of a pediatric cancer symptom screening tool. Psycho-Oncology. 25:349-353. 2016
- Classification of treatment-related mortality in children with cancer: a systematic assessment. The Lancet Oncology. 16:e604-e610. 2015
- IV administration of Erwinia-derived asparaginase in pediatric patients with acute lymphoblastic leukemia: Single-centre case series. Canadian Journal of Hospital Pharmacy. 68:481-484. 2015
- Predictors of diagnostic interval and associations with outcome in acute lymphoblastic leukemia. Pediatric Blood and Cancer. 62:957-963. 2015
- Lack of treatment-related mortality definitions in clinical trials of children, adolescents and young adults with lymphomas, solid tumors and brain tumors: a systematic review. BMC Cancer. 14:612. 2014
- Refinement of the Symptom Screening in Pediatrics Tool (SSPedi). British Journal of Cancer. 111:1262-1268. 2014
- Guideline for the prevention and treatment of anticipatory nausea and vomiting due to chemotherapy in pediatric cancer patients. Pediatric Blood and Cancer. 61:1506-1512. 2014
- Erratum to: Initial development of the Symptom Screening in Pediatrics Tool (SSPedi). Supportive Care in Cancer. 22:77-78. 2014
- Initial development of the Symptom Screening in Pediatrics Tool (SSPedi). Supportive Care in Cancer. 22:71-75. 2014
- Treatment with topotecan plus cyclophosphamide in children with first relapse of neuroblastoma. Pediatric Blood and Cancer. 60:1636-1641. 2013
- Prediction of Area under the Cyclosporine Concentration Versus Time Curve in Children Undergoing Hematopoietic Stem Cell Transplantation. Transplantation and Cellular Therapy. 19:418-423. 2013
- The Role of Tc-99m-DTPA Nuclear Medicine GFR Studies in Pediatric Solid Tumor Patients. Journal of Pediatric Hematology/Oncology. 35:108-111. 2013
- Do children with central venous line (CVL) dysfunction have increased risk of symptomatic thromboembolism compared to those without CVL-dysfunction, while on cancer therapy?. BMC Cancer. 12:314. 2012
- Mapping and modeling the capacities that underlie effective cross-cultural leadership An interpretive study with practical outcomes. Cross Cultural Management: an international journal. 16:347-366. 2009
- Relapse of Wilms' Tumor 13 Years After Original Diagnosis. Journal of Pediatric Hematology/Oncology. 27:293-294. 2005
other
- Preparing Hospital Electronic Medical Record Data for Research: Essential Data Validation 2023